MARKET

SNYNF

SNYNF

Sanofi FR
OTCPK
87.10
0.00
0.00%
Closed 10:17 08/14 EDT
OPEN
87.10
PREV CLOSE
87.10
HIGH
87.10
LOW
87.10
VOLUME
218
TURNOVER
18.99K
52 WEEK HIGH
98.26
52 WEEK LOW
83.09
MARKET CAP
104.35B
P/E (TTM)
23.39
1D
5D
1M
3M
1Y
5Y
1D
Nektar: Maintaining 'Strong Buy' Rating Due To REZPEG Catalyst, Another Coming
Seeking Alpha · 1d ago
Sanofi Shuts Down Early Cancer Drug Trial, Trimming One Piece of Its Oncology Pipeline
TipRanks · 1d ago
Sanofi Updates Share Capital and Voting Rights as of July 31, 2026
TipRanks · 2d ago
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
TipRanks · 4d ago
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
Seeking Alpha · 5d ago
Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer
TipRanks · 5d ago
Sanofi facing shortages of two drugs for Pompe disease, STAT reports
TipRanks · 5d ago
Weekly Report: what happened at SNYNF last week (0803-0807)?
Weekly Report · 5d ago
More
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA stock information, including OTCPK: SNYNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNYNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNYNF stock methods without spending real money on the virtual paper trading platform.